Biographical summary
Cecilia Arana Yi, M.D., is senior associate consultant and director of leukemia services. She received her medical degree at the Cayetano Heredia University in Lima, Peru, and completed residency at the University of Buffalo. She then completed a Hematology/Oncology fellowship at Thomas Jefferson University and a Leukemia fellowship at University of Texas MD Anderson Cancer Center. Dr. Arana Yi was the Leukemia Program Director and the Mastocytosis Multidisciplinary Program Leader at the University of New Mexico Comprehensive Cancer Center in Albuquerque, NM.
Dr. Arana Yi conducts clinical trials in acute and chronic leukemias, and systemic mastocytosis. She is a member of professional organizations including American Society of Hematology, American Association for Cancer Research, Association of Clinical Research Professionals, and is a well-recognized educator and speaker in educational meetings for community oncologists, families and caregivers.
Dr. Arana Yi’s clinical and research activities focus on acute and chronic leukemias, myelodysplastic syndromes, myeloproliferative neoplasms, and systemic mastocytosis.
Conditions treated
Interests
- Acute Leukemias
- Myelodysplastic syndromes
- Mastocytosis
Mayo Clinic locations
Phoenix, Arizona
Education
- 2013
Fellowship - LeukemiaMD Anderson Cancer Center
- 2012
Fellowship - Hematology/OncologyThomas Jefferson University Hospital
- 2009
Internship/Residency - Internal MedicineState University of New York at Buffalo
- 2004
Residency - Internal MedicineUniversidad Peruana Cayetano Heredia
- 2000
MD - Medical SurgeonUniversidad Peruana Cayetano Heredia
-
MSHS - Clinical and Translational ResearchGeorge Washington University
Activities and honors
Professional memberships
- 2019 - present
ProviderMastocytosis Society
- 2019 - present
MemberMastocytosis Society
- 2018 - present
MemberAmerican College of Physicians
- 2018 - present
MemberHemostasis and Thrombosis Research Society
- 2018 - 2020
MemberUNM Cancer Committee Survivorship Section, Comprehensive Cancer Center, University of New Mexico
- 2018 - present
MemberEuropean Hematology Association
- 2017 - present
MemberPeruvian Society of Hematology
- 2017 - present
MemberSociety of Hematologic Oncology
- 2017 - present
SpecialistMDS Foundation
- 2013 - 2020
MemberProtocol Review and Monitoring Committee, Comprehensive Cancer Center, University of New Mexico
- 2013 - 2020
MemberData Safety Review Committee, Comprehensive Cancer Center, University of New Mexico
- 2013 - 2020
MemberHematology Working Group, Comprehensive Cancer Center, University of New Mexico
- 2013 - 2020
MemberHematology Translational Research Committee, Comprehensive Cancer Center, University of New Mexico
- 2013 - present
MemberAmerican Association for Cancer Research
- 2013 - present
MemberAmerican Society of Hematology